# GO_biological_process_0152

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **D** — response to antibiotic

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MADTAITVDGAEKRYGDKKALDGLDLRVARGTVHGVLGPNGAGKTTLVRVLSTLLRPDAGRIEVSGHDVVREAYAVRLRIGLLGQHAALDEELGGRQNLELFGRLHHLGARRARARADELLERFDLADTGRKTVRQYSGGMRRRLDLAASLITEPEVLFLDEPTTGLDPRGRAEVWDSVRSLVGGGTTVLLTTQYLEEADQLADRISVVDAGRVIAEGTADELKAETGGDRIDVVLREAGQLGAAVALLPLTGVTVDTDRRLLSAPVTDRMEALSGVVRALQEAGIEAEDVALRRPTLDEVFLHLTGDDRRVKEAA

[Multiple Choices]
A. protein dephosphorylation
B. IRE1-mediated unfolded protein response
C. rRNA acetylation
D. response to antibiotic
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence match is annotated as the DrrA3 ATP-binding component of an ABC transporter involved in daunorubicin efflux, and the cited functional evidence says it confers self-resistance to this antibiotic. That supports the broader choice, response to antibiotic. The GO annotation itself is computationally assigned, but the cited functional description also supports the biological link.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [H3](#evidence-h3), [H6](#evidence-h6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence has features consistent with an ABC transporter ATP-binding protein, which makes transport more plausible than protein dephosphorylation, IRE1 signaling, or rRNA acetylation. Those features do not identify the transported substrate or establish an antibiotic-resistance role.


**Missing item-specific fact**

> The protein-specific link to the DrrA3B3 transporter, daunorubicin efflux, and resistance to daunorubicin is not given in the input.


**Reason**

> Choosing D depends on knowing the protein's particular antibiotic-efflux and resistance function; the sequence and choices alone do not establish that item-specific fact.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied evidence supports D among the listed choices. Although daunorubicin transport would describe the function more directly, it is not an offered option.


### Important caveats

- The cited functional annotation includes experimental evidence, while the specific GO annotation for response to antibiotic is keyword-based.
- The historical and current UniProt records match the supplied sequence, but the author's exact source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence has features consistent with an ABC transporter ATP-binding protein, which makes transport more plausible than protein dephosphorylation, IRE1 signaling, or rRNA acetylation. Those features do not identify the transported substrate or establish an antibiotic-resistance role.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific link to the DrrA3B3 transporter, daunorubicin efflux, and resistance to daunorubicin is not given in the input.",
    "reason": "Choosing D depends on knowing the protein's particular antibiotic-efflux and resistance function; the sequence and choices alone do not establish that item-specific fact."
  },
  "case_id": "GO_biological_process_0152",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "H3",
      "H6"
    ],
    "judgment": "supported",
    "reason": "The exact sequence match is annotated as the DrrA3 ATP-binding component of an ABC transporter involved in daunorubicin efflux, and the cited functional evidence says it confers self-resistance to this antibiotic. That supports the broader choice, response to antibiotic. The GO annotation itself is computationally assigned, but the cited functional description also supports the biological link."
  },
  "important_caveats": [
    "The cited functional annotation includes experimental evidence, while the specific GO annotation for response to antibiotic is keyword-based.",
    "The historical and current UniProt records match the supplied sequence, but the author's exact source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports D among the listed choices. Although daunorubicin transport would describe the function more directly, it is not an offered option."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0152",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence match is annotated as the DrrA3 ATP-binding component of an ABC transporter involved in daunorubicin efflux, and the cited functional evidence says it confers self-resistance to this antibiotic. That supports the broader choice, response to antibiotic. The GO annotation itself is computationally assigned, but the cited functional description also supports the biological link.",
    "evidence_ids": ["C1", "C5", "H3", "H6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence has features consistent with an ABC transporter ATP-binding protein, which makes transport more plausible than protein dephosphorylation, IRE1 signaling, or rRNA acetylation. Those features do not identify the transported substrate or establish an antibiotic-resistance role.",
    "missing_item_specific_fact": "The protein-specific link to the DrrA3B3 transporter, daunorubicin efflux, and resistance to daunorubicin is not given in the input.",
    "reason": "Choosing D depends on knowing the protein's particular antibiotic-efflux and resistance function; the sequence and choices alone do not establish that item-specific fact."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied evidence supports D among the listed choices. Although daunorubicin transport would describe the function more directly, it is not an offered option."
  },
  "important_caveats": [
    "The cited functional annotation includes experimental evidence, while the specific GO annotation for response to antibiotic is keyword-based.",
    "The historical and current UniProt records match the supplied sequence, but the author's exact source snapshot is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXU7 identifies this protein as DrrA3, a Daunorubicin resistance ATP-binding protein from Streptomyces coeruleorubidus. Experimental evidence (PubMed:39375957, ECO:0000269) confirms it is part of an ABC transporter complex involved in daunorubicin efflux and confers self-resistance to daunorubicin, an antibiotic. GO:0046677 'response to antibiotic' is explicitly annotated (IEA:UniProtKB-KW, evidence H6). The GO definition (GO3) encompasses processes resulting from an antibiotic stimulus, including resistance/efflux mechanisms. The other options are clearly incompatible: A requires phosphatase activity, B is a eukaryotic ER-stress pathway, C requires an acetyltransferase.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [C8](#evidence-c8), [H3](#evidence-h3), [H6](#evidence-h6), [GO3](#evidence-go3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a canonical Walker A motif (GNGAGKT at positions ~25-31) and a Walker B motif (GGTTVLL), identifying this as an ABC transporter nucleotide-binding domain. Among the four choices: (A) protein dephosphorylation requires phosphatase catalytic residues (e.g., PP1/PP2A/PTP motifs) absent here; (B) IRE1-mediated UPR is a eukaryotic ER-stress pathway incompatible with a bacterial protein; (C) rRNA acetylation requires an acetyltransferase domain (GNAT/PAF-like fold), not a P-loop NTPase. Only (D) 'response to antibiotic' is mechanistically compatible with a bacterial ABC efflux transporter. General knowledge that bacterial ABC efflux pumps are the principal self-resistance mechanism in antibiotic-producing actinomycetes supports the positive assignment.


**Missing item-specific fact**

> The exact substrate (daunorubicin) and the organism's role as a daunorubicin producer are protein-specific facts not derivable from the sequence alone. However, among the four provided choices, the elimination argument uniquely selects D without requiring that specific substrate knowledge.


**Reason**

> A model with general biochemistry knowledge can identify the P-loop/ABC-transporter architecture from the sequence and eliminate three mechanistically incompatible options, leaving D as the only viable choice. This constitutes a concrete biological argument grounded in the supplied sequence and general domain knowledge, not a lookup of this particular protein's database entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four options span four distinct protein function classes (phosphatase, eukaryotic signaling, acetyltransferase, transporter). Only one is compatible with the identifiable ABC-transporter architecture, so the choices are cleanly discriminated.


### Important caveats

- The GO annotation for 'response to antibiotic' (GO:0046677) carries evidence code IEA:UniProtKB-KW, a keyword-based inference rather than direct experimental annotation. The experimental evidence supports 'daunorubicin efflux' and 'self-resistance to daunorubicin' specifically.
- The sequence is only 316 aa, representing the NBD (nucleotide-binding domain) portion; the transmembrane permease partner (DrrB3) is not included. The full transporter function requires the partner protein.
- The protein was first publicly released in Feb 2025; the benchmark construction date is unknown, so the author may have sourced annotations from a pre-publication or very early annotation state.
- The identity origin note states the accession was inferred mechanically from dataset image-path metadata and was absent from the evaluated model input.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a canonical Walker A motif (GNGAGKT at positions ~25-31) and a Walker B motif (GGTTVLL), identifying this as an ABC transporter nucleotide-binding domain. Among the four choices: (A) protein dephosphorylation requires phosphatase catalytic residues (e.g., PP1/PP2A/PTP motifs) absent here; (B) IRE1-mediated UPR is a eukaryotic ER-stress pathway incompatible with a bacterial protein; (C) rRNA acetylation requires an acetyltransferase domain (GNAT/PAF-like fold), not a P-loop NTPase. Only (D) 'response to antibiotic' is mechanistically compatible with a bacterial ABC efflux transporter. General knowledge that bacterial ABC efflux pumps are the principal self-resistance mechanism in antibiotic-producing actinomycetes supports the positive assignment.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The exact substrate (daunorubicin) and the organism's role as a daunorubicin producer are protein-specific facts not derivable from the sequence alone. However, among the four provided choices, the elimination argument uniquely selects D without requiring that specific substrate knowledge.",
    "reason": "A model with general biochemistry knowledge can identify the P-loop/ABC-transporter architecture from the sequence and eliminate three mechanistically incompatible options, leaving D as the only viable choice. This constitutes a concrete biological argument grounded in the supplied sequence and general domain knowledge, not a lookup of this particular protein's database entry."
  },
  "case_id": "GO_biological_process_0152",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "C6",
      "C8",
      "H3",
      "H6",
      "GO3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXU7 identifies this protein as DrrA3, a Daunorubicin resistance ATP-binding protein from Streptomyces coeruleorubidus. Experimental evidence (PubMed:39375957, ECO:0000269) confirms it is part of an ABC transporter complex involved in daunorubicin efflux and confers self-resistance to daunorubicin, an antibiotic. GO:0046677 'response to antibiotic' is explicitly annotated (IEA:UniProtKB-KW, evidence H6). The GO definition (GO3) encompasses processes resulting from an antibiotic stimulus, including resistance/efflux mechanisms. The other options are clearly incompatible: A requires phosphatase activity, B is a eukaryotic ER-stress pathway, C requires an acetyltransferase."
  },
  "important_caveats": [
    "The GO annotation for 'response to antibiotic' (GO:0046677) carries evidence code IEA:UniProtKB-KW, a keyword-based inference rather than direct experimental annotation. The experimental evidence supports 'daunorubicin efflux' and 'self-resistance to daunorubicin' specifically.",
    "The sequence is only 316 aa, representing the NBD (nucleotide-binding domain) portion; the transmembrane permease partner (DrrB3) is not included. The full transporter function requires the partner protein.",
    "The protein was first publicly released in Feb 2025; the benchmark construction date is unknown, so the author may have sourced annotations from a pre-publication or very early annotation state.",
    "The identity origin note states the accession was inferred mechanically from dataset image-path metadata and was absent from the evaluated model input."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span four distinct protein function classes (phosphatase, eukaryotic signaling, acetyltransferase, transporter). Only one is compatible with the identifiable ABC-transporter architecture, so the choices are cleanly discriminated."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0152",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXU7 identifies this protein as DrrA3, a Daunorubicin resistance ATP-binding protein from Streptomyces coeruleorubidus. Experimental evidence (PubMed:39375957, ECO:0000269) confirms it is part of an ABC transporter complex involved in daunorubicin efflux and confers self-resistance to daunorubicin, an antibiotic. GO:0046677 'response to antibiotic' is explicitly annotated (IEA:UniProtKB-KW, evidence H6). The GO definition (GO3) encompasses processes resulting from an antibiotic stimulus, including resistance/efflux mechanisms. The other options are clearly incompatible: A requires phosphatase activity, B is a eukaryotic ER-stress pathway, C requires an acetyltransferase.",
    "evidence_ids": ["C4", "C5", "C6", "C8", "H3", "H6", "GO3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a canonical Walker A motif (GNGAGKT at positions ~25-31) and a Walker B motif (GGTTVLL), identifying this as an ABC transporter nucleotide-binding domain. Among the four choices: (A) protein dephosphorylation requires phosphatase catalytic residues (e.g., PP1/PP2A/PTP motifs) absent here; (B) IRE1-mediated UPR is a eukaryotic ER-stress pathway incompatible with a bacterial protein; (C) rRNA acetylation requires an acetyltransferase domain (GNAT/PAF-like fold), not a P-loop NTPase. Only (D) 'response to antibiotic' is mechanistically compatible with a bacterial ABC efflux transporter. General knowledge that bacterial ABC efflux pumps are the principal self-resistance mechanism in antibiotic-producing actinomycetes supports the positive assignment.",
    "missing_item_specific_fact": "The exact substrate (daunorubicin) and the organism's role as a daunorubicin producer are protein-specific facts not derivable from the sequence alone. However, among the four provided choices, the elimination argument uniquely selects D without requiring that specific substrate knowledge.",
    "reason": "A model with general biochemistry knowledge can identify the P-loop/ABC-transporter architecture from the sequence and eliminate three mechanistically incompatible options, leaving D as the only viable choice. This constitutes a concrete biological argument grounded in the supplied sequence and general domain knowledge, not a lookup of this particular protein's database entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four options span four distinct protein function classes (phosphatase, eukaryotic signaling, acetyltransferase, transporter). Only one is compatible with the identifiable ABC-transporter architecture, so the choices are cleanly discriminated."
  },
  "important_caveats": [
    "The GO annotation for 'response to antibiotic' (GO:0046677) carries evidence code IEA:UniProtKB-KW, a keyword-based inference rather than direct experimental annotation. The experimental evidence supports 'daunorubicin efflux' and 'self-resistance to daunorubicin' specifically.",
    "The sequence is only 316 aa, representing the NBD (nucleotide-binding domain) portion; the transmembrane permease partner (DrrB3) is not included. The full transporter function requires the partner protein.",
    "The protein was first publicly released in Feb 2025; the benchmark construction date is unknown, so the author may have sourced annotations from a pre-publication or very early annotation state.",
    "The identity origin note states the accession was inferred mechanically from dataset image-path metadata and was absent from the evaluated model input."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `P0DXU7` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 4. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXU7.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:39.757107+00:00.  

```json
"P0DXU7"
```

Source SHA-256: `e4ecbe95569eb6174ea1ce5042f5eb78567e393cf608a2fde3f152bb86370540`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXU7.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:39.757107+00:00.  

```json
{"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000305","id":"39375957","source":"PubMed"}],"value":"7.6.2.2"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000305"}],"value":"Daunorubicin resistance ATP-binding protein DrrA3"}}}
```

Source SHA-256: `e4ecbe95569eb6174ea1ce5042f5eb78567e393cf608a2fde3f152bb86370540`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXU7.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:39.757107+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"39375957","source":"PubMed"},{"evidenceCode":"ECO:0000305"}],"value":"Part of the ABC transporter complex DrrA3B3 involved in daunorubicin efflux (PubMed:39375957). Responsible for energy coupling to the transport system (Probable). Confers self-resistance to daunorubicin, an antibiotic produced by S.coeruleorubidus (PubMed:39375957). The efficiency of DrrA3B3 to export daunorubicin is probably lower than that of DrrA1B1 or DrrA2B2 (PubMed:39375957)"}]}
```

Source SHA-256: `e4ecbe95569eb6174ea1ce5042f5eb78567e393cf608a2fde3f152bb86370540`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXU7.json)  
**Locator:** `/uniProtKBCrossReferences/9`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:39.757107+00:00.  

```json
{"database":"GO","id":"GO:0043215","properties":[{"key":"GoTerm","value":"P:daunorubicin transport"},{"key":"GoEvidenceType","value":"IEA:InterPro"}]}
```

Source SHA-256: `e4ecbe95569eb6174ea1ce5042f5eb78567e393cf608a2fde3f152bb86370540`.

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXU7.json)  
**Locator:** `/references/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:29:39.757107+00:00.  

```json
{"citation":{"authors":["Dong J.","Ning J.","Tian Y.","Li H.","Chen H.","Guan W."],"citationCrossReferences":[{"database":"PubMed","id":"39375957"},{"database":"DOI","id":"10.1111/1751-7915.70023"}],"citationType":"journal article","firstPage":"e70023","id":"39375957","journal":"Microb. Biotechnol.","lastPage":"e70023","publicationDate":"2024","title":"The involvement of multiple ABC transporters in daunorubicin efflux in Streptomyces coeruleorubidus.","volume":"17"},"referenceNumber":2,"referencePositions":["FUNCTION IN DAUNORUBICIN EFFLUX","INDUCTION","DISRUPTION PHENOTYPE"]}
```

Source SHA-256: `e4ecbe95569eb6174ea1ce5042f5eb78567e393cf608a2fde3f152bb86370540`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXU7?format=txt&versions=4)  
**Locator:** `lines 26-32`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:44.049376+00:00.  

```text
CC   -!- FUNCTION: Part of the ABC transporter complex DrrA3B3 involved in
CC       daunorubicin efflux (PubMed:39375957). Responsible for energy coupling
CC       to the transport system (Probable). Confers self-resistance to
CC       daunorubicin, an antibiotic produced by S.coeruleorubidus
CC       (PubMed:39375957). The efficiency of DrrA3B3 to export daunorubicin is
CC       probably lower than that of DrrA1B1 or DrrA2B2 (PubMed:39375957).
CC       {ECO:0000269|PubMed:39375957, ECO:0000305}.
```

Source SHA-256: `42d20297633a41a19682385e9a7ca80ef7478fe940d29e171258f49592f4cbc9`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXU7?format=txt&versions=4)  
**Locator:** `lines 71-71`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 4 / 1.  
**Retrieved:** 2026-11-02T04:29:44.049376+00:00.  

```text
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
```

Source SHA-256: `42d20297633a41a19682385e9a7ca80ef7478fe940d29e171258f49592f4cbc9`.

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 279516-279527`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0046677
name: response to antibiotic
namespace: biological_process
def: "Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms." [GOC:ai, GOC:ef]
subset: goslim_chembl
synonym: "antibiotic susceptibility/resistance" RELATED []
xref: Reactome:R-HSA-9638771 "Action of antimicrobials"
xref: Reactome:R-HSA-9639775 "Antimicrobial action and antimicrobial resistance in Mtb"
xref: Reactome:R-HSA-9913143 "Antimicrobial resistance"
is_a: GO:0042221 ! response to chemical

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 152. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
